Background: Postoperative nausea and vomiting (PONV) is a common distressing experience in patients following laparoscopic surgeries. This study was aimed at comparing the ef¿ cacies of Ondansetron-Dexamethasone combination with each drug alone as a prophylaxis against PONV in patients after elective laparoscopic cholecystectomy done under general anaesthesia. 
T he overall incidence of PONV is estimated to be around 20 to 30% 1 and might peak up to 75% in certain high risk patients 2 . In the absence of prophylaxis 50-70% of patients undergoing laparoscopic cholecystectomy develop PONV 3, 4 . On top of discomfort and distress, PONV may lead to dehydration, electrolyte imbalance and subsequently delayed hospital discharge. It can also increase the risk of aspiration, wound dehiscence and prolonged wound bleeding. Patients who experience PONV consume more resources and require additional health care professional time 5 . PONV is also among the most unpleasant experiences associated with surgery and one of the most common reasons for poor patient satisfaction 6, 7 . Reduction of incidence of PONV, by utilizing various antiemetic interventions, has been shown to improve patient satisfaction and reduce the time to recovery and discharge 8, 9, 10, 11, 12, 13, 14 .
PONV can be alleviated, but not eliminated-there is no wonder drug for it. The major obstacle in solving this problem has been its multifactorial aetiology. The factors involved are not only numerous but also so diverse and often unavoidable such that a multipronged pharmacological approach rather than a single therapeutic agent needs to be devised to counter PONV.
Ondansetron is a 5 hydroxytryptamine type 3 receptor ) antagonist that has provided effective antiemesis in surgical patients 8, 10, 11, 12, 13, 14 . Dexamethasone is a glucocorticoid drug that has been successfully used as an antiemetic in patients undergoing chemotherapy, with limited side effects. 15 It has also been evaluated and found to be effective for the prevention of PONV 9, 16, 17 . Since any single antiemetic drug has been shown to have limited ef¿ cacy against PONV, multimodal therapy has been proposed. This approach, introduced ¿ rst for chemotherapy-induced nausea and vomiting is gaining popularity for PONV prophylaxis 18 . Most of the studies demonstrate improved prophylaxis with combination therapies 19, 20, 21 . The most commonly studied combinations have included a 5-HT 3 receptor antagonist with either Droperidol or Dexamethasone with comparable ef¿ cacies 22 .
This prospective, randomized, double-blind study was designed to compare the ef¿ cacy and safety of a single intravenous (IV) dose of combined OndansetronDexamethasone with each drug alone in the prevention of PONV in patients undergoing elective laparoscopic cholecystectomy. A randomization list was prepared before anaesthesia using a computer-generated random number table.
Material and methods
Identical syringes containing each treatment regimen were diluted with normal saline to make a volume of 5 ml by a personnel not involved in the study. Drug preparations were administered IV just before induction of anaesthesia.
Standardised anaesthetic regimen was employed for all patients. Anaesthesia was induced with 5 mg.kg -1
Thiopentone sodium IV and 1 mg.kg -1 Meperidine IV. Tracheal intubation was facilitated with Succinylcholine 1.5 mg.kg -1 IV and anaesthesia was maintained with halothane 0.75 to 2.5% in oxygen. Muscle relaxation was achieved with Norcuronium. Ventilation was mechanically controlled and was adjusted to maintain end-tidal carbon dioxide concentration at 30 to 35 mmHg. An orogastric tube was inserted and suction applied to empty the stomach of air and other contents.
Each anticipated portal site was in¿ ltrated with 3 ml of 0.25% Bupivacaine by the surgeon before making a mini incision. Abdomen was insufÀ ated with carbon dioxide (CO2) at a À ow rate of 0.2L/min and intraabdominal pressure (IAP) was maintained below 15 mmHg throughout surgery. Patients were positioned in reverse Trendelenburg position with left lateral tilt. Laparoscopic cholecystectomy was performed under video guidance with three punctures of the abdomen. At the end of the surgical procedure surgeons were encouraged to desufÀ ate the abdomen as completely as possible. The orogastric tube was suctioned and then removed. Residual neuromuscular blockade was antagonized with 0.04 mg.kg -1 Neostigmine and 0.02 mg.kg -1 Atropine IV. The trachea was extubated once the patient became awake. No other sedative, analgesic or antiemetic drug was administered. The variables recorded during intraoperative period included: total amounts of Meperidine and À uids administered, durations of carbon dioxide insufÀ ation, surgery and anaesthesia and occurrence of any hemodynamic instability.
Patients were monitored postoperatively for 24 hrs. Pain intensity scores were recorded at intervals of 2, 6, 12, and 24 hours using a 10 cm visual analogue scale (VAS) (0 = no pain, 10 = most severe pain). First dose of analgesia was provided with Meperidine 1 mg.kg -1 intramuscular (IM) when demanded by the patients and then followed by every eight hrs regimen or as demanded by the patients. Further analgesia was omitted if the patient was over sedated or pain free (< 3 on VAS). The time interval from extubation to the ¿ rst administration of Meperidine was recorded as the time for ¿ rst Meperidine demand. The total 24 hr consumption of Meperidine was also recorded.
While they were in the post anaesthesia care unit (until 6 hrs after operation) and in the ward (12 and 24 hrs post operation) the occurrence of PONV was recorded using the following numeric scale based on the patients' complaints: 0 = no nausea or vomiting • 1 = nausea only • 2 = retching and/or vomiting. • All observations were recorded by direct questioning (with only two possible answers of yes/no) by trained on-duty doctors blinded to the group assignment, or based on spontaneous complaint by the patients. The primary end point was a "complete response", de¿ ned as no episode of PONV during the ¿ rst 24 hrs after recovery from anaesthesia. Nausea was de¿ ned as the subjectively unpleasant sensation associated with an awareness of the urge to vomit. Vomiting was de¿ ned as the forceful expulsion of gastric contents from the mouth. Retching was de¿ ned as the laboured, spasmic, rhythmic contraction of the respiratory muscles without the expulsion of gastric content 7 . Retching was not assessed as a separate entity and was classi¿ ed under vomiting.
If two PONV score-points were reached or if patients speci¿ cally demanded antiemetic treatment in the presence of nausea, rescue antiemesis was provided with increments of 10 mg Metoclopramide IV. These patients were then injected the same drug at an interval of eight hrs. Failure of prophylaxis, considered as a need for rescue antiemetic, was recorded at six, 12 and 24 hrs. The PONV events occurring within six hrs were considered early PONV and those occurring after six hrs were considered as late PONV.
Details of any adverse event were recorded throughout the study period based on general questioning of the patients by trained on-duty doctors, or spontaneous mention by the patients, or observation by the caring nurses. Finally the duration of hospital stay for each patient was recorded.
Comparisons of incidence of PONV and need for a rescue antiemetic between groups were performed for overall study period and at different time intervals. Statistical analyses of data among the treatment groups were performed by one-way analysis of variance with Bonferroni correction for multiple comparisons, chisquared test, or Fisher's exact probability test, as appropriate. A p value of less than 0.05 was considered signi¿ cant. A sample size of 50 patients per group was required to achieve a power of 0.8 (Į = 0.05) to detect a large difference.
Results
Out of 150 patients enrolled, eight patients required conversion to open cholecystectomy because of surgical reasons and were excluded from the study. Data obtained from the remaining 142 patients were analyzed for interpretation.
Patient characteristics and the factors related to surgery and anaesthesia did not differ between the groups (Table 1 ). Time to ¿ rst Meperidine demand, VAS pain scores and Meperidine consumption during 24 hr period were similar among all groups ( Late antiemetic rescue, de¿ ned as a need for a rescue antiemetic after 6 hr, was higher in the Ondansetron group compared to group OD (p=0.032), but it was similar between groups O and D (p=0.273) ( Table 4 ).
The most frequently reported adverse event during the ¿ rst 24 hrs after recovery from anaesthesia was headache followed by throat discomfort, muscle pain, dizzinessdrowsiness, abdominal distension and urinary retention (Table 5 ). There were no signi¿ cant differences with regards to adverse events among the study groups. The duration of hospital stay among all the groups was also similar. . The latter advantage has been negated by PONV, which is turning out to be the leading cause of unexpected re-admission after ambulatory surgery 10 . Patients undergoing general anaesthesia for laparoscopic cholecystectomy have a high incidence of PONV, the aetiology being multifactorial. Risk factors that have been reported to be associated with the incidence of PONV include prolonged CO 2 Here we studied the incidence of PONV in patients undergoing laparoscopic cholecystectomy and compared the occurrence of PONV in patients who received different preoperative antiemetic regimens. PONV is a recognized complication of laparoscopic cholecystectomy; therefore we did not believe it to be ethical to include a placebo arm in our study. Our selection of drug dosages was based on previous works 12, 13, 16 . The study drugs are not known to be incompatible when mixed 27 . The number of known risk factors, and durations of anaesthesia, surgery, and CO 2 insufÀ ation were similar among patients assigned to the three different treatment groups. Patients also received similar amounts of perioperative IV À uids and Meperidine. Therefore, we believe that differences in the incidence of PONV in the present study can be attributed to the difference in the antiemetics that were administered.
During 24 hrs after recovery from anaesthesia, the frequencies of PONV and the need for rescue antiemetic in patients who received a combination of Ondansetron and Dexamethasone were signi¿ cantly lower than those in patients who received either drug alone. As single drugs for preoperative use as antiemetics, Ondansetron and Dexamethasone were found to be equally effective. The results of our studies are in agreement with that from McKenzie and colleagues 19 who have also shown lower PONV scores in the combination group. Similarly, Lopez-Olando et al 21 have also reported higher (84%) complete response in patients administered with Ondansetron and Dexamethasone but no signi¿ cant difference in the frequencies of PONV between patients who received Ondansetron or Dexamethasone only.
Although they could not assign statistical signi¿ cance Biswas et al 28 have also reported a decreased incidence of emetic episodes in patients receiving both antiemetics compared to those receiving only one.
In this study, during the ¿ rst six hrs, the incidence of vomiting and need for rescue antiemetic was signi¿ cantly higher in patients who received Dexamethasone compared to both other groups. Ondansetron and Ondansetron-Dexamethasone combination were equally effective in preventing early PONV. This indicates that Dexamethasone is not particularly effective in preventing vomiting occurring early in the postoperative period. Thomas and Jones 29 have shown a failure of prophylaxis during the ¿ rst 3 hr in 28.3% of patients who had received Dexamethasone compared to 22 and 8.6% of patients who had received Ondansetron and Ondansetron plus Dexamethasone respectively. Rajeeva et al 30 have demonstrated that the combination of Ondansetron and Dexamethasone provides better control of delayed PONV rather than early PONV.
In this study, in the late postoperative period (6-24 hr) patients in the Ondansetron group required more frequent antiemetic rescue compared to patients in the combination group (P=0.032). Although the number of patients requiring late antiemetic rescue was higher in the Ondansetron group compared to that in the Dexamethasone group, the difference was not statistically signi¿ cant (P=0.273). This sort of late failure of prophylaxis in the Ondansetron group may have been contributed to by the shorter duration of action of Ondansetron compared to that of Dexamethasone. Similar to other 5-HT 3 antagonists, Ondansetron has got a serum half-life of 4-9 hrs 8, 13, 14 . Subramaniam and Madan 31 have shown that the incidence of early PONV (0-6 hr) in children who received Dexamethasone was 24.4% compared with 17.8% in children who received Ondansetron. They also showed that the incidence of late PONV (6-24 hr) was signi¿ cantly lower with Dexamethasone (6.67%) than with Ondansetron (24.4%). Similar ¿ ndings have been reported in patients undergoing ambulatory surgery 17, 32, 33 . Dexamethasone has also been shown to provide greater protection from delayed chemotherapy-induced nausea and vomiting compared with Ondansetron 34 .
Corticosteroids interact with speci¿ c receptor proteins in target tissues to regulate the expression of corticosteroid-responsive genes, thereby changing the levels and array of proteins synthesized by the various target tissues. As a consequence of the time required for changes in gene expression and protein synthesis, most effects of corticosteroids are not immediate but become apparent after several hrs. The late onset and prolonged antiemetic ef¿ cacy of Dexamethasone may be attributed to its prolonged biological half-life (36-72 hr) 35 .
An insigni¿ cant decrease in Meperidine consumption was observed in patients who received Dexamethasone. With its strong anti-inÀ ammatory action, Dexamethasone has been shown to decrease postoperative pain 36 . In our study, the time to ¿ rst Meperidine administration, and pain scores were similar among patients in the three groups. Pain from multiple sources as after laparoscopic cholecystectomy may not be lessened with Dexamethasone.
There were no associated hemodynamic changes in any of the patients. The lack of difference in hospital stay or side effects among groups in our study suggests that a single dose of these study drugs is safe. Further largerscale studies and a longer follow-up are indicated.
Ondansetron is a selective 5-HT 3 antagonist shown to be effective in preventing nausea and vomiting associated with cancer chemotherapy 37 and radiation therapy 38 as well as that occurring postoperatively 8, 10, 12, 13, 14 . The reported side effects include headache, dizziness, À ushing, elevated liver enzymes and constipation.
Dexamethasone is a glucocorticoid that produces a strong antiemetic effect in preventing PONV at a recommended dose of 5 to 10 mg in adults 17 . It may act through prostaglandin antagonism 15 , central or peripheral inhibition of serotonin 39 , by releasing endorphins 40 and changes in the permeability of the blood CSF barrier to serum proteins 35 . However, there is no experimental proof to support these hypotheses.
Is an ounce of prevention worth a pound of cure? Despite the advances we have achieved in ensuring quality medical care we have still not been able to solve the seemingly simple problem of PONV which remains a major challenge and has been a perpetual dilemma since the birth of the speciality of anaesthesia and critical care medicine. PONV has long overwhelmed clinicians as a real problem. It has caused discomfort and dissatisfaction to patients across the globe. Nevertheless, little light has been shed on its aetiology during the operative period. Some patients have a history of severe PONV and some surgical procedures are almost invariably associated with PONV. So we feel justi¿ ed in exploring therapeutic possibilities, even if they might not be very effective, because to do nothing seems callous, even cruel.
The obvious limitations of this study include the lack of assessment of frequency, duration and severity of nausea and vomiting. Similarly, the study was not extended beyond 24 hrs after recovery from anaesthesia. In addition, satisfactions of the patients with regards to overall management were not assessed. Despite that it is clear from our study that patients at high risk for PONV who are treated prophylactically with combination therapy are overall less likely to require rescue antiemetics than if treated with a single agent. Larger studies that circumvent the limitations of the study are expected to allow for helping in determining the optimal regimen and timing of administration of prophylactic antiemetic therapy for different surgical scenarios and subsequently in establishing evidencebased guidelines for cost-effective therapy.
In conclusion, the combination of Ondansetron and Dexamethasone is better than each antiemetic alone as a prophylaxis against PONV following laparoscopic cholecystectomy and that Dexamethasone alone is not effective in preventing early PONV, especially vomiting. In addition, Ondansetron alone is less effective against late PONV compared to combined Ondansetron and Dexamethasone therapy.
